Obesity/NASH/Dyslipidemia/Fatty Liver Disease Therapeutic (Oneday)

N/A

Report date: 2025/01/26 16:33:31
NME

Base Information

Drug NameObesity/NASH/Dyslipidemia/Fatty Liver Disease Therapeutic (Oneday)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAppetite suppressant
TargetsUpdating
Therapy Area/IndicationsObesityLipid Metabolism DisordersMetabolic Dysfunction-Associated Steatotic Liver Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOneday - Biotech & Pharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesOneday - Biotech & Pharma Ltd
Inactive CompaniesN/A
Active IndicationsObesityLipid Metabolism DisordersMetabolic Dysfunction-Associated Steatotic Liver Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A